FDA sees tamper-proof advantage in OxyContin version

09/22/2009 | Google

FDA scientists said a plasticlike coating for Purdue Pharma's painkiller OxyContin offers "limited" tamper-proof qualities, but that the version of the drug might "provide an advantage" over regular OxyContin. A panel of advisers will meet Thursday to review additional data on OxyContin.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC